Welcome to the Prostate Cancer Center of Seattle
In 1985, Dr. Peter Grimm and his colleagues pioneered modern prostate brachytherapy ( Seed Implantation) in the US. Dr Grimm has treated over 6,000 patients and trained over 6,000 physicians, nurses and physicists to perform seed implantation. He is the lead editor of the Prostate Cancer Treatment Book and leads a distinguished group of worldwide experts The Prostate Cancer Results Study Group which researches the latest outcomes and results. Following the retirement of Dr John Blasko in 2009, Dr Grimm established a new center, the Prostate Cancer Center of Seattle, as a premier center for the diagnosis and treatment of primary and recurrent prostate cancer. Our center is dedicated to developing the latest technologies in diagnosis and treatment of prostate cancer for you.
In the News
Should I screen for prostate cancer? Prostate cancer (PC) is the second leading cause of cancer-related mortality in men, with approximately 28,000 deaths per year. Screening for PC with the prostate-specific antigen (PSA) test carries some controversy, and patient questions arise about whether to have a PSA test, when, and how to interpret the test results .
PSA screening has reduced prostate cancer mortality up to 31%, according to findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Recent Randomized trial demonstrated Superiority of External Beam and seed implantation for intermediate and high risk PCA
Connected Seed Technology for Permanent Seed Implantation
Connected seeds either Thin Strands or Source Link by Bard are proving to result in improved dosimetry and side effects
Prostate Cancer Results Study Group updates 04/15 Comparative Effectiveness of Prostate Cancer Treatments
Dr. Grimm, lead author, has published the report from the Prostate Cancer Results Study Group comparing treatment results for prostate cancer Update of this important work by a gorup a worldwide experts is now available at www.pctrf.org
Prostate Cancer Center of Seattle Physicians using Focal Therapies to Treat Recurrent Prostate Cancer
Patients with Local Failure after Seed implantation or External Beam radiation have limited options. PCCS physicians are embarking on new diagnostic and therapeutic strategies to treat this patients and preserve function.
PCCS strives to meet the highest standards of care for our patients through individual care, clinical research and the latest in advanced prostate cancer technology. We are dedicated to improving the quality of life and increasing better treatment outcomes in every patient we see. Please contact us for either a personal or telephone appointment